Thyroid Immune-Related Adverse Events Among Cancer Patients Treated With Combination of Anti-PD1 and Anti-CTLA4 Immune-Checkpoint Inhibitors: Clinical Course and Outcomes

Introduction: Thyroid immune-related adverse events (irAEs) have been reported to have prognostic significance among cancer patients treated with anti-PD1 and anti-PDL1 monotherapies. There are scanty data in the literature thus far about the clinical course and prognostic significance of thyroid ir...

Descripción completa

Detalles Bibliográficos
Autores principales: Lui, David T W, Lee, Chi Ho, Tang, Vikki, Fong, Carol H Y, Lee, Alan C H, Chiu, Joanne W Y, Leung, Roland C Y, Kwok, Gerry G W, Li, Bryan C W, Cheung, Tan To, Woo, Yu Cho, Lam, Karen S L, Yau, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090404/
http://dx.doi.org/10.1210/jendso/bvab048.1729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090404/
http://dx.doi.org/10.1210/jendso/bvab048.1729

Ejemplares similares